Comparison of the Effect of Inhaled Spray of Symbicort with Zenhale.
Phase 2
- Conditions
- Patients with Asthma are in stage of 3 and 4..Asthma
- Registration Number
- IRCT20150107020592N17
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Patients Over 12 years old
Asthma diagnosed using spirometry with and without salbutamol
Patients should be placed in stages 3 and 4 in terms of severity of the disease.
Exclusion Criteria
Cardiovascular patients
Asthma attack has led to hospitalization in the last six months
BMI above 35
Chronic illnesses, such as occupational diseases
Chronic obstructive pulmonary disease
Interstitial lung disease
Nasal polyps and sinusitis
Esophageal reflux
Heart failure
Oral candidiasis
Desphony
Pregnancy
smokers
People with specific food allergies
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method se of salbutamol. Timepoint: Less than twice a week / more than twice a week. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method Forced Expiratory Volume in One Second (FEV1). Timepoint: Pre and post intervention. Method of measurement: Spirometry.;Duration of hospitalization. Timepoint: After intervention. Method of measurement: questionnaire.;Number of night paroxysmal in a month. Timepoint: After intervention. Method of measurement: questionnaire.